ABSTRACT Morphine sulfate (MSO4) has been demonstrated to attenuate the stress response. MSO4 might be useful in minimizing the stress associated with the perioperative period, particularly that due to awakening from anesthesia and rewarming. Two groups of critically ill patients who developed hypothermia (35.8°C) during a surgical procedure were studied. The control group was observed during routine medical management. Group II received 1 or 4 mg/kg MSO4 followed by an infusion of 0.2 or 0.5 mg/kg/hr. During the postoperative rewarming period the control group patients demonstrated.a major increase in metabolic demand and myocardial work. In group II patients the infusion of MSO4 resulted in a lower metabolic rate. This was associated with a significantly longer rewarming time and a significant reduction in shivering, heat loss, heart rate, mean arterial pressure, and ratepressure product. Infusion of MSO in critically ill patients during the perioperative period suppressed metabolic demands and myocardial work while preserving cardiovascular function. Circulation 68, No. 6, 1238-1246, 1983 IN THE MODERN intensive care unit maintenance of physiologic homeostasis is important; increasing attempts are being made to define, measure, and control stresses encountered by the critically ill. In recent years, prolonged intra-abdominal and thoracic procedures in patients with compromised cardiopulmonary function have become commonplace. However, the metabolic changes that accompany these procedures often place a major stress on the cardiovascular system. These surgical procedures are often performed in air-conditioned operating rooms on patients under general anesthesia. 
IN THE MODERN intensive care unit maintenance of physiologic homeostasis is important; increasing attempts are being made to define, measure, and control stresses encountered by the critically ill. In recent years, prolonged intra-abdominal and thoracic procedures in patients with compromised cardiopulmonary function have become commonplace. However, the metabolic changes that accompany these procedures often place a major stress on the cardiovascular system. These surgical procedures are often performed in air-conditioned operating rooms on patients under general anesthesia. The combination of an open body cavity, a cool operating room, and general anesthesia (which abolishes the normal compensatory mechanisms such as peripheral vasoconstriction and shivering) has resulted in a greater number of such patients becoming hypothermic during the operative period.'
In the immediate postoperative period the simultaneous recovery from anesthesia, metabolic response to injury, and rewarming often result in marked increases of metabolic rate and myocardial work.4 Morphine sulfate (MSO4) has become an integral part of therapy figure 1 . The 02 cost of rewarming (% CRVO2), metabolic heat production, heat loss, and change in body heat content were calculated as described in the Appendix.
Resting energy expenditure (REE, calories/day) was calculated from measurements of Vo, and Vco2. Nitrogen excretion was estimated with the use of principles of indirect calorimetry. 16, 17 The rate-pressure product (RPP), defined as the product of systolic blood pressure 
Results
The clinical characteristics of the two groups of patients at the time of entry into the study are given in tables IA and lB. The patients in the two groups were comparable with respect to weight, body surface area, and operative time. Patients in group II were significantly (p < .05) older than those in group I.
Intraoperative fluids administered to patients in group I were (mean ± SE) colloids, 2.5 + 0.4 1, and crystalloids, 4 .07 + 0.4. Fluid administration in the perioperative rewarming period consisted of 5% dextrose plus one-half normal saline at 113 ± 9.4 ml/hr infused at room temperature. The Boums Bear 1 ventilator settings (mean ± SE) were VE, 8 Shivering occurred for 64% of the rewarming period in the control group, while there was a significant increase (p < .05) in REE from admission to the intensive care unit to PS (figure 2).
A comparison of group I and group II patients revealed that a constant MSO4 infusion (0.2 or 0.5 mg/ kg/hr) resulted in the following: in both groups had elevated serum lactate concentrations on admission (normal, 2.0 mmol/l), which returned to normal at ES.
The significant decrease in metabolic parameter values observed in group II could have been secondary to the lower intrinsic metabolic rate in the elderly and not to the MSO4 infusion. To evaluate this possibility, we compared two smaller (n = 5) age-matched groups. Patients 1, 2, 3, 6, and 7 (67 ± 9 years) from group I were compared with patients 2, 3, 5, 7, and 9 (69 ± 7 years) from group II. REE, TVo2, BVo2, amount of Vo2 above baseline, metabolic heat production, heat loss, HR, MAP, and RPP were significantly (p < .05) reduced in the smaller group II at the same points previously mentioned when compared with in the smaller group I. Hemodynamic and biochemical parameter values paralleled those of the two larger groups; Paco2 significantly increased (p < .05) in both small groups. 
Discussion
Increasing numbers of patients with systemic disease who undergo major surgery are being admitted to the intensive care unit on an elective basis. The routine use of invasive monitoring, cardiopulmonary drugs, and the greater appreciation of physiologic mechanisms has improved our ability to maintain homeosta- TABLE 3 sis during the operative period. An important component in the maintenance of homeostasis is the control of stress factors that may be detrimental. Three stress factors often affect patients simultaneously on admission to the intensive care unit: (1) awakening from anesthesia, (2) response to operative injury, and (3) postoperative rewarming. These stress factors have been demonstrated to increase Vo2, Vco2, VE, and cardiac output. II Furthermore, when cardiac output does not meet the requirements for oxygen delivery, arterial hypoxemia may result.5 In a previous study by our group,24 total abolition of shivering with a neuromuscular blocking agent eliminated the rapid rise in Vo2, Vco2, and RPP associated with shivering.
In this study the infusion of MSO4 in hypothermic critically ill patients lowered TVco2, BVo2, REE, metabolic heat production, and heat loss for a similar change in body heat content as the control group. Although CRVO2 was similar in both the control and morphine groups, it was accomplished at a lower metabolic expenditure in the morphine group. This reflects the greater economy of the rewarming system in patients on morphine: the metabolic generation of heat was conserved for rewarming instead of being lost.
The metabolic effects of MSO4 observed in the present study were similar to that observed by Rouby et al.
(a 21% decrease in Vo2).9 10 In contrast to the hemodynamic data obtained by Rouby et al. CI, LVWI, SI, and cardiac filling pressure increased as rewarming took place. At the same time, myocardial work (HR, MAP, RPP) was significantly lower. There are several possible explanations for these findings. First, the different patient populations in the two studies could be partially responsible for the different results. All of the patients studied by Rouby et al. were over the most acute phase of the disease process and were metabolically and hemody- In both groups, even though CO2 production was markedly lower in group II, there was a rise in CO2 production between A and ES. This was paralleled by an increase in Paco2, while VE was constant throughout the study period. In clinical practice, if VE is regulated to maintain a Paco2 of 40 to 45 torr, the clinician may encounter respiratory acidosis as rewarming takes place. As a result, frequent monitoring of arterial blood gas levels is mandatory; furthermore, it should be noted that ventilatory settings that are appropriate early in the rewarming period may not provide adequate VE for gas exchange later in the perioperative period.
In conclusion, using a noninvasive procedure for indirect calorimetry, routine hemodynamic monitoring, and laboratory chemistries, we have defined the immediate postoperative changes in metabolic rate and hemodynamic function that occur after major operative procedures, particularly those complicated by the development of intraoperative hypothermia. A MSO4 infusion during this period was able to control the rapid increase in metabolic rate and circulatory demands associated with this period while preserving cardiovascular function. In critically ill patients, especially those with underlying cardiovascular disease, the rapid increases in metabolic and hemodynamic parameters that occur after major surgery may not be well tolerated. Serious consideration should be given to the use of MS04 during the immediate postoperative period. However, it should be noted that the period required to rewarm will be extended, that postoperative fluid requirements will increase, and that the patient will require mechanical ventilation. T, when a straight line was drawn from V02 to the last recorded V02. The integration, as illustrated in figure 1, was computed for both groups. Amount of Vo2 above baseline was calculated as the difference between TVo2 and BVo2.
The % CRVO2 was defined as TVo2 -BVo2 x 100 TVo9
Thermodynamic principles dictate that heat production (M) + heat loss (HL) = change in body heat content (BHC). Therefore, HL = M -BHC. It should be noted that HL and BHC are related to the validity of esophageal temperature as a measure of whole-body temperature and energy content. Alterations in perfusion that lead to the closing down of vascular beds will reduce the validity of this assumption. However, total metabolic heat production is related to whole-body gas exchange, not to esophageal temperature. The study duration in the two groups varied. Consequently, heat loss, metabolic heat production, and change in body heat content can be calculated: 
